Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) in patients with unresectable biliary tract cancer treated with gemcitabine, cisplatin, and durvalumab.
Saved in:
| Title: | Prognostic impact of neutrophil-to-lymphocyte ratio (NLR) in patients with unresectable biliary tract cancer treated with gemcitabine, cisplatin, and durvalumab. |
|---|---|
| Authors: | Mii, Satoshi1 (AUTHOR), Kato, Hiroyuki2 (AUTHOR) katohiroyuki510719@gmail.com, Takahara, Takeshi1 (AUTHOR), Kojima, Masayuki1 (AUTHOR), Kato, Yutaro2 (AUTHOR), Morise, Zenichi3 (AUTHOR), Horiguchi, Akihiko2 (AUTHOR), Suda, Koichi1,4 (AUTHOR) |
| Source: | World Journal of Surgical Oncology. 7/1/2025, Vol. 23 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
